Last Updated on October 6, 2024 by The Health Master
I. IPC 2024
The Indian Pharmaceutical Congress 2024 (IPC 2024) is set to unveil its 73rd edition in Hyderabad from July 5 to 7, 2024.
Hosted at the HITEX city, this event organized by the Indian Pharmaceutical Association (IPA) holds immense significance in the pharmaceutical industry.
II. Event Details
A. Date, Venue, and Theme
IPC 2024, slated for July, embraces the theme ‘Indian Pharma for Global Wellbeing.’ The shift from its traditional December schedule is attributed to state elections and venue unavailability.
B. Organizing Body and Key Figures
Dr. T V Narayana, national president of IPA, highlights the event’s importance in addressing industry challenges.
Dr. B. Partha Saradhi Reddy, chairman of Hetero Group of Companies and IPCA president, plays a pivotal role.
C. Reason for the Change
The change in schedule and venue challenges reflects the complexities of organizing such a grand event amidst elections and venue constraints.
III. Indian Pharmaceutical Industry
A. Overview of Industry’s Resilience
The Indian pharmaceutical industry demonstrated resilience during the Covid-19 pandemic, supplying medicines and vaccines globally.
Dr. Narayana commends the industry’s role in crisis management.
B. Industry Challenges
Facing pricing pressures, increased competition, and regulatory standards, IPC 2024 aims to address these challenges, including intellectual property issues.
C. Significance of IPC 2024
Positioned as a platform to garner attention to industry issues, IPC 2024 becomes crucial in sustaining and propelling the growth of the pharmaceutical sector.
IV. Leadership and Organization
A. President of IPCA
Dr. B. Partha Saradhi Reddy, a member of the Rajya Sabha, leads IPCA, bringing valuable insights to the event.
B. Chairman of the Local Organising Committee
A S Giri‘s leadership in the committee ensures the seamless organization of the event, contributing to its success.
C. Significance of Leadership
Strong leadership ensures a well-organized and impactful event that addresses the industry’s pressing concerns.
V. Choice of Venue
A. Reasons for Selecting Hyderabad
Hyderabad, a pharmaceutical hub with a significant number of companies, becomes the ideal venue.
The city’s role as the bulk drug capital adds to its appeal.
B. Hyderabad’s Prominence
The Medak cluster in Hyderabad contributes significantly to India’s bulk drug production and exports.
C. Contribution of Telangana
Telangana’s increasing prominence as a pharma hub further justifies the choice of Hyderabad as the event venue.
VI. Focus on Pharma Industry Representation
A. Previous Trends
Historically, IPC had a notable presence of pharmacy students, with the industry being underrepresented.
B. Efforts to Increase Representation
Dr. Narayana‘s efforts aim to shift the focus towards the industry, making it the pivot of the event.
C. Dr. Narayana’s Vision
The concerted effort to elevate the industry’s presence in IPC aligns with Dr. Narayana’s vision for the event’s evolution.
VII. Pharmaceutical Industry in India
A. Role in the Country’s Economy
The pharmaceutical industry plays a critical role in India’s economy and healthcare system.
B. ‘Pharmacy of the World’
India’s robust generic drug manufacturing capabilities earned it the title of the ‘pharmacy of the world.’
C. Global Healthcare Accessibility
Contributing significantly to global healthcare accessibility, the Indian pharmaceutical industry remains indispensable.
VIII. Event Sessions and Highlights
A. Overview of Sessions
IPC 2024’s sessions cover current industry-relevant topics, including a CEO Conclave and B2B meetings.
B. CEO Conclave and B2B Meetings
These sessions provide a platform for industry leaders to discuss and strategize, fostering collaboration.
C. Expected Participation
Over 8,000 delegates from the industry, academia, hospitals, regulatory bodies, and pharmacy professional associations are expected to participate.
IX. Exhibitor Information
A. Overview of the Exhibitor (Orbit)
Orbit, the exhibitor of IPC 2024, adds value by showcasing innovations and contributing to the event’s success.
B. Importance of Exhibitors
Exhibitors play a crucial role in enhancing the event experience, providing a glimpse into the latest advancements in the pharmaceutical sector.
X. Conclusion
A. Recap of IPC 2024 Significance
IPC 2024 emerges as a pivotal event, addressing industry challenges, fostering collaboration, and propelling the growth of the pharmaceutical sector.
B. Anticipation for Positive Outcomes
The industry looks forward to positive outcomes, discussions, and collaborations that will shape the future of Indian pharmaceuticals.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
XI. FAQs
A. How Can I Register for IPC 2024?
To register for IPC 2024, visit the official website and follow the registration process outlined there.
B. What Are the Key Challenges Faced by the Indian Pharmaceutical Industry?
The industry faces challenges such as pricing pressures, increased competition, and the need for compliance with global regulatory standards.
C. How Does IPC Contribute to the Growth of the Industry?
IPC serves as a platform for industry leaders to discuss challenges, share insights, and strategize for the growth of the pharmaceutical sector.
D. What Topics Will Be Covered in the CEO Conclave?
The CEO Conclave will cover a range of industry-relevant topics, including the future of pharmaceuticals, innovation, and global collaboration.
E. Can Students Participate in IPC 2024?
Yes, students can participate in IPC 2024. The event welcomes diverse attendees, including students, to engage and learn from the industry’s leaders.
The 5th Round of PLI Scheme Applications in Medical Devices
International Drug Racket busted, Rs 3 Crore Worth of Medicines Seized
USFDA approval granted for this Kidney Disease Drug
3 PLI Schemes: Transforming India’s Pharma Industry
Unlocking Opportunities: Pharmexcil Urges Exporters to Embrace DGFT Amnesty Scheme
Drug alert: 2921 out of 89729 samples declared as NSQ in 2022-23
CDSCO to restrict Common Cold and Flu Medicine
USFDA issues EIR For APL Healthcare of Aurobindo
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
